Home › Lung Cancer › NCT00897117
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RecruitingObservational study
Molecular Fingerprinting of Lung Cancer
Who can join
Ages 18 to 120 · All sexes
Full eligibility criteria
Inclusion criteria * Diagnosis of non-small cell lung cancer * Clinical stage I and II disease * Resectable disease and complete surgical resection planned * Treated on companion studies at Vanderbilt University, the Veterans Administration hospital, St. Thomas, and Vanderbilt-Ingram Cancer Center Affiliate Network * Tumor specimen samples must be available at resection Exclusion criteria * Chemotherapy before surgery * Radiotherapy before surgery
About the study
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and identify biomarkers related to cancer.
PURPOSE: This research study is collecting and analyzing lung tissue samples from patients undergoing surgery for non-small cell lung cancer.
What is being tested
- gene expression analysis (genetic)
- microarray analysis (genetic)
- protein expression analysis (genetic)
- biologic sample preservation procedure (other)
- laboratory biomarker analysis (other)
- matrix-assisted laser desorption/ionization time of flight mass spectrometry (other)
Sponsor: Vanderbilt-Ingram Cancer Center · Participants: 4,000 · Started: May 1, 2001
Contact the study team
- VICC Clinical Trials Information Program · Phone: 800-811-8480
Official record on ClinicalTrials.gov — NCT00897117
Locations in the U.S.
| Tennessee | Vanderbilt-Ingram Cancer Center, Nashville |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.